Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Dividends payables Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Operating Leases Other Non-Current Assets Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Medifast (MED) Current Taxes (2016 - 2025)

Medifast's Current Taxes history spans 12 years, with the latest figure at $2.6 million for Q1 2025.

For Q1 2025, Current Taxes changed N/A year-over-year to $2.6 million; the TTM value through Mar 2025 reached $2.6 million, changed N/A, while the annual FY2024 figure was $1.5 million, N/A changed from the prior year.
Current Taxes reached $2.6 million in Q1 2025 per MED's latest filing, up from $1.5 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $13.0 million in Q1 2023 to a low of $428000.0 in Q4 2022.
Average Current Taxes over 4 years is $3.9 million, with a median of $2.1 million recorded in 2024.